Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Net Cash Flow (2016 - 2025)

Celcuity's (CELC) quarterly Net Cash Flow came in at $91.5 million in Q4 2025, up 822.63% YoY from $9.9 million in Q4 2024, and up 227.8% on a QoQ basis from $27.9 million in Q3 2025.

Analysis

Celcuity (CELC) Net Cash Flow (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Net Cash Flow data on file, last reported at $91.5 million in Q4 2025.

  • Quarterly Net Cash Flow rose 822.63% year-over-year to $91.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $143.2 million (up 1857.34% YoY) and the FY2025 annual result came in at $143.2 million, up 1857.34% from the prior year.
  • Net Cash Flow rose to $91.5 million in Q4 2025, from $27.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $91.5 million in Q4 2025 to a low of -$32.9 million in Q4 2022.
  • A 5-year average of $7.7 million and a median of -$102000.0 in 2024 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 4051.85% in 2025, down 1193.66% in 2025.
  • Tracing CELC's Net Cash Flow over 5 years: stood at -$6.1 million in 2021, then slumped by 441.28% to -$32.9 million in 2022, then jumped by 114.9% to $4.9 million in 2023, then soared by 102.17% to $9.9 million in 2024, then surged by 822.63% to $91.5 million in 2025.
  • The last three Net Cash Flow figures came in at $91.5 million (Q4 2025), $27.9 million (Q3 2025), and $29.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 91.45 Mn
Sep 30, 2025 27.90 Mn
Jun 30, 2025 29.88 Mn
Mar 31, 2025 -6.04 Mn
Dec 31, 2024 9.91 Mn
Sep 30, 2024 -17.86 Mn
Jun 30, 2024 -756,000.00
Mar 31, 2024 552,000.00
Dec 31, 2023 4.90 Mn
Sep 30, 2023 -6.48 Mn
Jun 30, 2023 -1.40 Mn
Mar 31, 2023 9.07 Mn
Dec 31, 2022 -32.91 Mn
Sep 30, 2022 -9.43 Mn
Jun 30, 2022 -11.38 Mn
Mar 31, 2022 -5.99 Mn
Dec 31, 2021 -6.08 Mn
Sep 30, 2021 48.73 Mn
Jun 30, 2021 6.70 Mn
Mar 31, 2021 23.30 Mn